A Phase I/II Study of Oblimersen in Combination With Cisplatin and Fluorouracil in Patients With Advanced Esophageal, Gastro-Esophageal Junction and Gastric Cancer
Phase of Trial: Phase I/II
Latest Information Update: 07 Jul 2015
At a glance
- Drugs Cisplatin (Primary) ; Oblimersen (Primary) ; Fluorouracil
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 31 Dec 2011 Additional lead trial centre (Montefiore Medical Center) identified as reported by ClinicalTrials.gov.
- 08 Aug 2005 New trial record.